Literature DB >> 32014439

Neuropeptide Y neurons in the nucleus accumbens modulate anxiety-like behavior.

Shunji Yamada1, Mohammad Shyful Islam1, Nienke van Kooten1, Sonny Bovee1, Yoon-Mi Oh1, Atsushi Tsujimura2, Yoshihisa Watanabe2, Masaki Tanaka3.   

Abstract

Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that is widely expressed in the central nervous system, including the cerebral cortex, nucleus accumbens (NAc) and hypothalamus. We previously analyzed the behavior of transgenic mice exclusively expressing an unedited RNA isoform of the 5-HT2C receptor. These mice showed decreased NPY gene expression in the NAc and exhibited behavioral despair, suggesting that NAc NPY neurons may be involved in mood disorder; however, their role in this behavior remained unknown. Therefore, in the present study, we investigated the functional role of NAc NPY neurons in anxiety-like behavior by examining the impact of specific ablation or activation of NAc NPY neurons using NPY-Cre mice and Cre-dependent adeno-associated virus. Diphtheria toxin-mediated ablation of NAc NPY neurons significantly increased anxiety-like behavior in the open field and elevated plus maze tests, compared with before toxin treatment. Moreover, chemogenetic activation of NAc NPY neurons reduced anxiety-like behavior in both behavioral tests compared with control mice. These results suggest that NPY neurons in the NAc are involved in the modulation of anxiety in mice.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety-like behaviors; Designer receptors exclusively activated by designer drugs; Diphtheria toxin receptor; Neuropeptide Y; Nucleus accumbens

Mesh:

Substances:

Year:  2020        PMID: 32014439     DOI: 10.1016/j.expneurol.2020.113216

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  Social subordination induced by early life adversity rewires inhibitory control of the prefrontal cortex via enhanced Npy1r signaling.

Authors:  Lara O Franco; Mário J Carvalho; Jéssica Costa; Pedro A Ferreira; Joana R Guedes; Renato Sousa; Mohamed Edfawy; Catarina M Seabra; Ana L Cardoso; João Peça
Journal:  Neuropsychopharmacology       Date:  2020-06-03       Impact factor: 7.853

Review 2.  Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect.

Authors:  Wei-Can Chen; Yi-Bin Liu; Wei-Feng Liu; Ying-Ying Zhou; He-Fan He; Shu Lin
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

Review 3.  The Role of Neuropeptide Y in the Nucleus Accumbens.

Authors:  Masaki Tanaka; Shunji Yamada; Yoshihisa Watanabe
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.